This Metric Says You Are Smart to Sell Lexicon Pharmaceuticals, Inc. (LXRX)

Page 2 of 2

With the returns demonstrated by our research, everyday investors must always monitor hedge fund and insider trading activity, and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an important part of this process.

Click here to learn why you should track hedge funds

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Nektar Therapeutics (NASDAQ:NKTR) 9 0 0
PDL BioPharma Inc. (NASDAQ:PDLI) 14 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 16 0 1
VIVUS, Inc. (NASDAQ:VVUS) 19 0 0
Santarus, Inc. (NASDAQ:SNTS) 16 1 12
Page 2 of 2